Below are the most recent publications written about "Mass Spectrometry" by people in Profiles.
-
Joseph KM, Boatman AK, Dodds JN, Kirkwood-Donelson KI, Ryan JP, Zhang J, Thiessen PA, Bolton EE, Valdiviezo A, Sapozhnikova Y, Rusyn I, Schymanski EL, Baker ES. Multidimensional library for the improved identification of per- and polyfluoroalkyl substances (PFAS). Sci Data. 2025 Jan 25; 12(1):150.
-
Agrohia DK, Goswami R, Jantarat T, ?i?ek YA, Thongsukh K, Jeon T, Bell JM, Rotello VM, Vachet RW. Suborgan Level Quantitation of Proteins in Tissues Delivered by Polymeric Nanocarriers. ACS Nano. 2024 Jul 02; 18(26):16808-16818.
-
Ivanov DG, Cheung K, Kaltashov IA. Probing the Architecture of Multisubunit Protein Complexes with In-line Disulfide Reduction and Native MS Analysis. Anal Chem. 2024 05 28; 96(21):8243-8248.
-
Levy HL, Sahai I. Is More Effective Newborn Screening for Homocystinuria on the Horizon? Clin Chem. 2023 04 28; 69(5):433-434.
-
Kaltashov IA, Ivanov DG, Yang Y. Mass spectrometry-based methods to characterize highly heterogeneous biopharmaceuticals, vaccines, and nonbiological complex drugs at the intact-mass level. Mass Spectrom Rev. 2024 Jan-Feb; 43(1):139-165.
-
Haque HME, Ejemel M, Vance DJ, Willsey G, Rudolph MJ, Cavacini LA, Wang Y, Mantis NJ, Weis DD. Human B Cell Epitope Map of the Lyme Disease Vaccine Antigen, OspA. ACS Infect Dis. 2022 12 09; 8(12):2515-2528.
-
Davis HC, Pan X, Kirsch ZJ, Vachet RW, Tew GN. Covalent Labeling-Mass Spectrometry Provides a Molecular Understanding of Noncovalent Polymer-Protein Complexation. ACS Biomater Sci Eng. 2022 06 13; 8(6):2489-2499.
-
Yang W, Ivanov DG, Kaltashov IA. Extending the capabilities of intact-mass analyses to monoclonal immunoglobulins of the E-isotype (IgE). MAbs. 2022 Jan-Dec; 14(1):2103906.
-
Jung SM, Le J, Doxsey WG, Haley JA, Park G, Guertin DA, Jang C. Stable Isotope Tracing and Metabolomics to Study In Vivo Brown Adipose Tissue Metabolic Fluxes. Methods Mol Biol. 2022; 2448:119-130.
-
Foureau D, Bhutani M, Guo F, Rigby K, Leonidas M, Tjaden E, Fox A, Atrash S, Paul B, Voorhees PM, Usmani SZ. Comparison of mass spectrometry and flow cytometry in measuring minimal residual disease in multiple myeloma. Cancer Med. 2021 10; 10(20):6933-6936.